Christer Rosen - 02 Jun 2026 Form 4 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Reporting relationship: CEO and Chairman, Director
Issuer ticker: JUNS
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 21:00:30 UTC
Prior SEC filing: 03 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Christer Rosen

Key filing fact

Christer Rosen filed Form 4 for JUPITER NEUROSCIENCES, INC. (JUNS) on 04 Jun 2026.

Key facts

This page summarizes Christer Rosen's Form 4 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 21:00.

Change

Previous filing in this sequence was filed on 03 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000902453 Primary reporting owner

ROSEN CHRISTER

Relationship: CEO and Chairman, Director
Address: C/O JUPITER NEUROSCIENCES, INC., 1001 NORTH US HYWAY 1, SUITE 504, JUPITER
Signature: /s/ Christer Rosen
Signature date: 04 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JUNS transaction Derivative

Stock Option

Award

Transaction value
Shares: +747,783
Change %
Price: $0.000000^*
Shares after: 747,783
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 747,783
Exercise price: $0.2783
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

747,783 options were granted under the Issuer's 2025 Equity Incentive Plan as a discretionary bonus for services rendered during fiscal 2025. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued employment through each vesting date.